• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Glycation increases the vascular clearance rate of IgG in mice.糖基化增加了小鼠体内IgG的血管清除率。
Clin Exp Immunol. 1993 Dec;94(3):447-51. doi: 10.1111/j.1365-2249.1993.tb08216.x.
2
Glycation of monoclonal antibodies impairs their ability to bind antigen.单克隆抗体的糖基化会损害其结合抗原的能力。
Clin Exp Immunol. 1994 Nov;98(2):245-51. doi: 10.1111/j.1365-2249.1994.tb06133.x.
3
Catabolism of unglycated and naturally glycated forms of rabbit fibrinogen: their interaction with the healthy and deendothelialized aorta wall in normal and diabetic rabbits.兔纤维蛋白原未糖化和天然糖化形式的分解代谢:它们在正常和糖尿病兔中与健康及去内皮主动脉壁的相互作用。
J Lab Clin Med. 1993 Apr;121(4):588-97.
4
Effect of glycation of albumin on its renal clearance in normal and diabetic rats.白蛋白糖基化对正常及糖尿病大鼠肾脏清除率的影响。
Kidney Int. 1988 Mar;33(3):673-6. doi: 10.1038/ki.1988.52.
5
Differential clearance of glycoforms of IgG in normal and autoimmune-prone mice.正常小鼠和自身免疫易感性小鼠中IgG糖型的差异清除率。
Clin Exp Immunol. 1996 Nov;106(2):259-64. doi: 10.1046/j.1365-2249.1996.d01-847.x.
6
Impact of glycation on antibody clearance.糖基化对抗体清除的影响。
AAPS J. 2015 Jan;17(1):237-44. doi: 10.1208/s12248-014-9694-4. Epub 2014 Nov 21.
7
IgG glycation and function during continuous ambulatory peritoneal dialysis.
Nephrol Dial Transplant. 1997 Feb;12(2):310-4. doi: 10.1093/ndt/12.2.310.
8
Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn.缺乏β2-微球蛋白的小鼠中IgG清除率增加:FcRn的可能保护作用。
Immunology. 1996 Dec;89(4):573-8. doi: 10.1046/j.1365-2567.1996.d01-775.x.
9
Increased accumulation of nonenzymatically glycated fibrinogen in the renal cortex in rats.
Thromb Res. 1990 Apr 1;58(1):23-33. doi: 10.1016/0049-3848(90)90240-d.
10
In vitro glycation of human immunoglobulin G.人免疫球蛋白G的体外糖基化
Clin Chim Acta. 2004 Jul;345(1-2):105-11. doi: 10.1016/j.cccn.2004.03.026.

引用本文的文献

1
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants.重组单克隆抗体电荷变体的基于风险的控制策略
Antibodies (Basel). 2022 Nov 20;11(4):73. doi: 10.3390/antib11040073.
2
Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody Detection.诱导型英夫利昔单抗清除率升高预示早期抗药物抗体检测。
J Clin Pharmacol. 2021 Feb;61(2):224-233. doi: 10.1002/jcph.1732. Epub 2020 Sep 9.
3
Dashboards for Therapeutic Monoclonal Antibodies: Learning and Confirming.治疗性单克隆抗体的仪表盘:学习与确认。
AAPS J. 2018 Jun 14;20(4):76. doi: 10.1208/s12248-018-0237-2.
4
Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat.2型糖尿病和糖尿病肾病对大鼠IgG药代动力学及皮下生物利用度的影响。
AAPS J. 2015 Jul;17(4):965-75. doi: 10.1208/s12248-015-9771-3. Epub 2015 Apr 30.
5
Impact of glycation on antibody clearance.糖基化对抗体清除的影响。
AAPS J. 2015 Jan;17(1):237-44. doi: 10.1208/s12248-014-9694-4. Epub 2014 Nov 21.
6
Non enzymatic glycosylation of IgG and their urinary excretion in patients with diabetic nephropathy.糖尿病肾病患者中IgG的非酶糖基化及其尿排泄
Indian J Clin Biochem. 2009 Apr;24(2):159-65. doi: 10.1007/s12291-009-0029-7. Epub 2009 Jul 9.
7
Covalent binding antibodies suppress advanced glycation: on the innate tier of adaptive immunity.共价结合抗体抑制晚期糖基化:在适应性免疫的先天层次上。
Acta Naturae. 2009 Jul;1(2):66-72.
8
Reactive immunization suppresses advanced glycation and mitigates diabetic nephropathy.反应性免疫抑制可抑制晚期糖基化并减轻糖尿病肾病。
J Am Soc Nephrol. 2009 May;20(5):1012-9. doi: 10.1681/ASN.2008050555. Epub 2009 Apr 23.
9
Transcytosis and catabolism of antibody.抗体的转胞吞作用与分解代谢
Immunol Res. 2002;25(2):97-113. doi: 10.1385/IR:25:2:097.
10
Aberrant glycosylation of IgA from patients with IgA nephropathy.IgA肾病患者IgA的异常糖基化。
Glycoconj J. 1996 Aug;13(4):505-11. doi: 10.1007/BF00731436.

本文引用的文献

1
Infection and diabetes: the case for glucose control.感染与糖尿病:血糖控制的理由
Am J Med. 1982 Mar;72(3):439-50. doi: 10.1016/0002-9343(82)90511-3.
2
Nonenzymatic glucosylation of lysine residues in albumin.白蛋白中赖氨酸残基的非酶糖基化作用。
Methods Enzymol. 1984;106:88-98. doi: 10.1016/0076-6879(84)06010-9.
3
Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes.可溶性蛋白质通过非酶糖基化胶原蛋白的共价连接。在免疫复合物原位形成中的作用。
J Exp Med. 1983 Nov 1;158(5):1739-44. doi: 10.1084/jem.158.5.1739.
4
Studies of an unusual hemoglobin in patients with diabetes mellitus.糖尿病患者中一种异常血红蛋白的研究。
Biochem Biophys Res Commun. 1969 Aug 22;36(5):838-43. doi: 10.1016/0006-291x(69)90685-8.
5
Metabolism of immunoglobulins.免疫球蛋白的代谢
Prog Allergy. 1969;13:1-110. doi: 10.1159/000385919.
6
Nonenzymatic glycation of immunoglobulins leads to an impairment of immunoreactivity.
Biol Chem Hoppe Seyler. 1985 Apr;366(4):361-6. doi: 10.1515/bchm3.1985.366.1.361.
7
Diabetes mellitus and infection.糖尿病与感染。
Postgrad Med J. 1985 Mar;61(713):233-7. doi: 10.1136/pgmj.61.713.233.
8
Evidence for an increased glycation of IgG in diabetic patients.
Clin Chim Acta. 1987 Jul 15;166(2-3):143-53. doi: 10.1016/0009-8981(87)90416-5.
9
Nonenzymatic glycosylation of serum IgG and its effect on antibody activity in patients with diabetes mellitus.糖尿病患者血清免疫球蛋白G的非酶糖基化及其对抗体活性的影响。
Diabetes. 1987 Jul;36(7):822-8. doi: 10.2337/diab.36.7.822.
10
Nonenzymatic glycation of immunoglobulins does not impair antigen-antibody binding.
Clin Chem. 1987 May;33(5):692-4.

糖基化增加了小鼠体内IgG的血管清除率。

Glycation increases the vascular clearance rate of IgG in mice.

作者信息

Kennedy D M, Skillen A W, Self C H

机构信息

Department of Clinical Biochemistry, Medical School, University of Newcastle Upon Tyne, UK.

出版信息

Clin Exp Immunol. 1993 Dec;94(3):447-51. doi: 10.1111/j.1365-2249.1993.tb08216.x.

DOI:10.1111/j.1365-2249.1993.tb08216.x
PMID:8252805
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1534424/
Abstract

As elevated levels of glycated IgG have been detected in the plasma of diabetics we have investigated whether glycation of IgG affects its vascular clearance rate, using a mouse model system. Polyclonal mouse IgG was aseptically incubated for 14-19 days with 0.5 M glucose in 0.1 M phosphate buffer (pH 7.4) at 37 degrees C. As control, IgG was incubated under identical conditions but with no added glucose. After incubation, both forms were labelled with 125I and injected intravenously into BALB/c mice. The rate of vascular clearance of the glycated IgG was found to be significantly higher than the control IgG in the periods 5-24 h (P < 0.001, n = 6) and 24-48 h (P < 0.01, n = 6) after injection. After 2-3 days the mice were killed and the major organs were harvested. With glycated IgG there was a significant increase in the 125I accumulated in the kidney (P < 0.02). In later experiments, dual labelling with 131I and 125I allowed mixtures of glycated and unglycated IgG to be injected into the same mouse so that the vascular clearance of both forms of IgG could be followed simultaneously. These experiments confirmed that glycation of the IgG significantly increases its vascular clearance rate.

摘要

由于在糖尿病患者血浆中检测到糖化IgG水平升高,我们使用小鼠模型系统研究了IgG糖基化是否会影响其血管清除率。将多克隆小鼠IgG在37℃下于0.1M磷酸盐缓冲液(pH 7.4)中与0.5M葡萄糖无菌孵育14 - 19天。作为对照,IgG在相同条件下孵育,但不添加葡萄糖。孵育后,两种形式都用125I标记,并静脉注射到BALB/c小鼠体内。发现糖化IgG在注射后5 - 24小时(P < 0.001,n = 6)和24 - 48小时(P < 0.01,n = 6)的血管清除率显著高于对照IgG。2 - 3天后处死小鼠并收获主要器官。对于糖化IgG,肾脏中积累的125I有显著增加(P < 0.02)。在后续实验中,用131I和125I进行双重标记,使得糖化和未糖化IgG的混合物可以注射到同一只小鼠体内,从而能够同时追踪两种形式IgG的血管清除情况。这些实验证实,IgG的糖基化显著提高了其血管清除率。